Twist Bioscience Corp (TWST) Stock Price & Analysis

Twist Bioscience Corp (TWST) fell 3.10% to USD 124.72 as of September 8, 2026 at 04:21 UTC, according to Nexqual real-time market data.

TWST last closed at USD 124.72; the session ranged USD 123.75–128.13 on volume of 901,850 shares. Market capitalization is —, with a 52-week range of USD 23.3–155.44 (NMS). Source: Nexqual, September 8, 2026 at 04:21 UTC.

Key Statistics (as of September 8, 2026 at 04:21 UTC)

Technical Analysis (TWST)

Nexqual's technical model rates TWST "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:21 UTC.

From Twist Bioscience Corp's Latest SEC 10-K Filing (filed 2025-11-17)

Key Strengths & Strategy (as disclosed to the SEC)

• The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip.
• Our Platform We developed the Twist Bioscience DNA synthesis platform to address the limitations of throughput, scalability, and cost inherent in legacy DNA synthesis methods.
• This growing convergence highlights the power of our integrated platform and reinforces Twist's unique position to serve the full spectrum of innovation in discovery.
• We have combined our silicon-based DNA writing technology with proprietary software, scalable commercial infrastructure and an e-commerce platform to create an integrated technology platform that enables us to achieve high levels of quality, precision, automation, and manufacturing throughput at a significantly lower cost and quicker than our competitors.

Partnerships

• In October 2024, we entered into an agreement with XOMA Royalty under which they paid Twist $15 million cash in exchange for 50% of future milestone and royalty payments from our existing collaborations as of the date of signing.
• Research and development activities are conducted in collaboration with manufacturing activities to help expedite new products from the development phase to manufacturing and to more quickly implement new process technologies.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:21 UTC. This page is informational and not investment advice.